コンテンツへスキップ
Merck
  • Direct neuronal conversion of microglia/macrophages reinstates neurological function after stroke.

Direct neuronal conversion of microglia/macrophages reinstates neurological function after stroke.

Proceedings of the National Academy of Sciences of the United States of America (2023-10-09)
Takashi Irie, Taito Matsuda, Yoshinori Hayashi, Kanae Matsuda-Ito, Akihide Kamiya, Takahiro Masuda, Marco Prinz, Noriko Isobe, Jun-Ichi Kira, Kinichi Nakashima
要旨

Although generating new neurons in the ischemic injured brain would be an ideal approach to replenish the lost neurons for repairing the damage, the adult mammalian brain retains only limited neurogenic capability. Here, we show that direct conversion of microglia/macrophages into neurons in the brain has great potential as a therapeutic strategy for ischemic brain injury. After transient middle cerebral artery occlusion in adult mice, microglia/macrophages converge at the lesion core of the striatum, where neuronal loss is prominent. Targeted expression of a neurogenic transcription factor, NeuroD1, in microglia/macrophages in the injured striatum enables their conversion into induced neuronal cells that functionally integrate into the existing neuronal circuits. Furthermore, NeuroD1-mediated induced neuronal cell generation significantly improves neurological function in the mouse stroke model, and ablation of these cells abolishes the gained functional recovery. Our findings thus demonstrate that neuronal conversion contributes directly to functional recovery after stroke.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
タモキシフェン, ≥99%
Sigma-Aldrich
抗NeuN抗体、クローンA60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
抗グリア線維性酸性タンパク質抗体, Chemicon®, from chicken
Sigma-Aldrich
抗MAP2(2a+2b)抗体、マウスモノクローナル マウス宿主抗体, clone AP-20, ascites fluid
Sigma-Aldrich
抗グリア原線維酸性タンパク質 ウサギ宿主抗体, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-CUX1 Antibody, a.a. 861, from rabbit, purified by affinity chromatography